In addition to preserving hemostasis, fibrinogen assembly on leukocytes mediates inflammatory responses and may aberrantly contribute to vascular injury. In this study, we used real-time intravital video microscopy in exposed rabbit mesentery to investigate the potential role of fibrinogen on leukocyte adherence mechanisms, in vivo. At physiologic concentrations of 0.15 to 0.5 mg/mL, human fibrinogen dose-dependently enhanced by threefold to fivefold the adhesion of chemoattractant-stimulated monocytic HL-60 cells to rabbit mesenteric endothelium, by acting as a bridging molecule between the two cell types. Fibrinogen-dependent intercellular bridging occurred in venules, but not in arterioles or capillaries (I), was optimal at reduced flow shear forces (range: 0.77 to 2.79 dynelcm') (2) . and produced a firm attachment of monocytic cells to endothelium, rather than transient rolling (3). Consistent with this model, rabbit fibrinogen failed to support human leukocyte adhesion, while human fibrinogen enhanced monocytic cell attach-T HAS BEEN appreciated for more than 2 decades that I blood clotting mechanisms contribute to inflammatory responses in vivo.' Particularly, the use of systemically defibrinogenated animals has shown that fibrinogen plays a primary pathogenetic role in the formation of intraabdominal abscesses during purulent infections,' in mediating severe intraglomerular tissue damage in acute nephrotoxic nephritis,3 and in promoting recruitment of inflammatory cells onto biomaterial implant^.^ Furthermore, fibrinogen degradation products exhibited chemotactic and proinflammatory properties on polymorphonuclear leukocytes,' and profoundly downmodulated lymphocyte effector functiom6
Among the several membrane receptors that coordinate the assembly of fibrinogen on leukocyte^,^ the inducible and high affinity recognition of fibrinogen by the myelo-monocytic integrin CD1 lb/CD18 (Mac-1, aMP2) has been shown to play a primary role in a variety of vascular cell effector ment to rabbit endothelial cells in vitro, in a reaction indistinguishable from that observed with human endothelium. Antagonists of the recently described association of fibrinogen with intercellular adhesion molecule-I (ICAM-I), including monoclonal antibodies (MoAbs) LB-2 or 2D5, or the fibrinogen y3 peptide yA~n"'-Ala'~~, blocked fibrinogen-dependent leukocyte-endothelium interaction in vitro or in vivo, respectively, while a control nonbinding antibody or the fibrinogen L10 peptide y L e~~' -V a l~" were ineffective. These data suggest that simultaneous assembly of fibrinogen on leukocytes and endothelial ICAM-1 provides a pathway of intercellular adhesion which may act in concert with & integrins to stabilize firm leukocyte attachment to endothelium, in vivo. Given the recognized role of fibrinogen as a major risk factor for atherosclerosis, this mechanism may directly contribute to thrombus formation and endothelial cell damage in vascular diseases.
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functions, including procoagulant activity, intracellular signaling with generation of second messengers, cytokine release, production of oxidative radicals, and intercellular adh e~i o n .~ Specifically, fibrinogen has been shown to act as a bridging molecule to enhance leukocyte attachment to endothelial cells in vitro,8 through a simultaneous interaction with CD1 lb/CD18 on the leukocyte and intercellular adhesion molecule-1 (ICAM-1)' on the endothelium. This novel recognition of fibrinogen by endothelial ICAM-1 has been independently substantiated in recent studies, with respect to cytoskeletal requirements for ligand binding," and its signaling role in vascular wall relaxation. '' In view of the considerable interspecies homology and conservation of function between human and rabbit vascular cell adhesion molecules,'2.'3 it has recently become possible to examine the interaction between human leukocytes and rabbit endothelial cells in the mesenteric circulation at physiological shear rates, in vivo.'4.'' Using real-time intravital video microscopy in exposed rabbit me~entery,'~.'' we have now re-investigated the potential contribution of fibrinogen to the multistep "adhesion cascade" of leukocyte-endothelium interaction, in v~v o . '~. '~ We have found that fibrinogen mediates firm attachment of monocytic cells to endothelium in a shear stress-dependent mechanism, and that this pathway of intercellular bridging was abrogated by monoclonal antibody (MoAb) or synthetic peptide antagonists of the ICAM-I -fibrinogen recognition.'.'' For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From published protocols.'9 De novo induction of differentiation-specific monocytic markers, including CD1 lb/CD18, on vitamin D3-treated HL-60 cells was confirmed by flow cytometry, in agreement with previous observations?'.'' Published comparative studies showed that vitamin D3-differentiated HL-60 and monocytic THP-1 cells were indistinguishable for their ability to bind fibrinogen and adhere to human umbilical vein endothelial cells in a fibrinogen-dependent manner, thus providing reliable models for this pathway of intercellular bridging.'.'' Rabbit endothelial cells were isolated from the jugular vein as described?' Briefly, animals were anesthetized with a single intramedullary (i.m.) injection of ketamine (25 mgkg) mixed with xylazine (Rompun, 5 m a g ) , and complete anesthesia was maintained during the entire procedure by intravenous administration of 0.5 to 1.0 mL of ketamine/xylazine mixture through an intravenous catheter placed in the marginal ear vein. After unilateral neck incision, the external jugular vein was exposed, followed by ligation of all visible branches. A proximal and a distal silk loops were placed and tied at the thoracic outlet and at the angle of the jaw, respectively. After venotomy with a n.11 blade, the vessel was flushed with M-199 medium containing 10 U/mL heparin prewarmed at 37"C, followed by excision in proximal to distal fashion, and immediately processed for endothelial cell culture. Cells were obtained under sterile conditions by collagenase treatment (0.2% Worthington type I collagenase in M-199 medium plus 1% FBS), washed, and plated in complete tissue culture medium containing M-199 plus 20% FBS, 100 pg/mL endothelial cell growth factor, 2 mmoVL L-glutamine, 17.5 U/mL heparin (Sigma; porcine intestinal mucosa) onto gelatin-coated 24-well tissue culture plates (Costar Corp, Cambridge, MA). Cells were maintained in culture for 4 to 6 passages, and functionally characterized as described previously.'' Cell labeling and jibrinogen-dependent intercellular bridging. Vitamin D,-differentiated HL-60 cells (1 X 107/mL) in phosphatebuffered saline (PBS), pH 7.4, containing 0.01% glucose were fluorescently labeled with 20 pg/mL carboxy fluorescein diacetate (CFDA; Molecular Probes, Eugena, OR) for 30 minutes at 22°C in the dark with intermittent agitation, as described previo~sly.'~ At the end of the incubation, cells were washed, suspended in PBS, pH 7.4, containing 0.01% glucose at 1 X 107/mL, and kept in the dark at 22°C until use. To test the effect of fibrinogen on leukocyteendothelium interaction in vivo, vitamin D,-treated, CFDA-labeled HL-60 cells at 0.2 to 1 X 107/mL were stimulated or not with 10 pmoVL of the chemoattractant formyl-methionyl-leucyl phenylalanine (fMLP; Sigma) and incubated with increasing concentrations of plasma-purified human fibrinogen: for 20 minutes at 37°C before perfusion into the rabbit superior mesentery artery (see below). fMLP-stimulation of HL-60 cells resulted in transient increased affinity of CD1 lb/CD18 for fibrinogen binding, in agreement with previous observation^.^ In another series of experiments, aliquots (1 X 106/mL) of monocytic THP-1 or vitamin D3-differentiated HL-60 cells were labeled with 0.5 mCislCr (Amersham, Arlington Heights, IL) for 1.5 hours at 3 7 T , with a final incorporation of 3 to 7 cpmkell. After washes in PBS, pH 7.4, cells were suspended in serum-free RPMI 1640, stimulated with 10 pmoVL MLP, and equilibrated with human or rabbit fibrinogen (300 pg/mL), or control protein transferrin (300 pg/mL) in the presence of 2.5 mmoVL CaCl'. After 20 minutes of incubation at 22T, cells were separately added to confluent monolayers of human or rabbit endothelial cells for increasing time intervals between 10 and 90 minutes at 37°C. At the end of each incubation, wells were washed three times with serum-free RPMI 1640, and attached cells were solubilized in 20% sodium dodecyl sulfate (SDS) with determination of radioactivity in a scintillation p counter. In inhibition experiments, monolayers of human or rabbit endothelial cells were incubated with 25 pg/mL aliquots of functionally blocking anti-ICAM-1 MoAbs LB-2;' 2D5,'' or control nonbinding MoAb 14Ell for 20 minutes at 37°C before addition of 51Cr-labeled THP-1 cells pre-equilibrated with human fibrinogen, and determination of leukocyte-endothelium interaction after a 30-minute interval at 37T, as described above. The effect of fibrinogen peptidyl antagonists" on monocytic cell adhesion to rabbit mesenteric endothelium in vivo was investigated as follows. Increasing concentrations (0 to 2.0 mg/mL) of fibrinogen y-chain-derived synthetic peptides y3 ( A~n "~-A l a '~~) , L10 (Leua2-Val4"), or a control peptide with the y3 sequence synthesized in scrambled order were perfused in the rabbit mesentery circulation (see below) simultaneously with fMLP (10 pmoVL)-stimulated, CFDA-labeled HL-60 cells, equilibrated with 300 pglmL human fibrinogen before injection, as described above. Peptides were greater than 95% pure as judged by high-performance liquid chromatography purification. Endotoxin contamination in purified fibrinogen preparations or the fibrinogen-derived synthetic peptides used in this study was always less than 70 pg/mL, as measured by the Limulus Amebocyte assay, according to the manufacturer's specifications (Associates of Cape Cod, Inc, Woods Hole, MA).
MATERIALS AND METHODS

Cells
Ninety-six well microtiter plates (Costar) were coated with increasing concentrations of human or rabbit fibrinogen (0.4 to 50 pg/mL), or control protein transferrin, in PBS, pH 7.4, for 16 hours at 4°C. After washes in PBS, pH 7.4, wells were postcoated with 3% bovine serum albumin (BSA; Sigma) for 30 minutes at 37"C, rinsed, and incubated with 0.1 mL aliquots of fMLP-stimulated "Cr-labeled THP-1 cells ( 1 X 1 06/mL) for 45 minutes at 37°C. In some experiments, THP-1 cells were pre-equilibrated with antLCD18 MoAb IB4 for 20 minutes at 22°C before addition to substrate-coated plates. At the end of the incubation, wells were washed three times with PBS, pH 7.4, and attached cells were solubilized in 20% SDS with determination of radioactivity in a scintillation p counter.
Real-time adhesion of vitamin D3-differentiated HL-60 cells to endothelium in vivo was assessed in the mesenteric circulation of New Zealand White rabbits, as described p r e v i~u s l y~~*~~ with the following modifications. Briefly, animals (1.2 to 1.5 kg body weight) were sedated with i.m. injection of 0.1 mL 0.1% droperidol and 0.002% fentanyl (Mallinckrodt Veterinary, Mundelein, IL) and orally administered with loperamide hydrochloride (2 mg/1.5 mL PBS) to reduce intestinal peristalsis. Surgical anesthesia was subsequently induced with 5 to 10 mL 20% urethane intravenously and animals were prepared for in vivo observation as d e~c r i b e d .~~.~~ The animals were placed on a heating pad (37°C) controlled by a rectal thermistor. A tracheal tube was placed to facilitate breathing. This was followed by insertion of catheters in the right carotid artery for continuous maintenance of blood pressure or to draw blood samples, and in the left jugular vein for continuous administration of saline containing anticoagulant PPACK at 5 pg/ kg/min body weight. A mid-line abdominal incision was made and the terminal ileum was exteriorized and spread on a heated glass window (37°C) of the stage of a Leitz intravital microscope (Wetzlar, Germany). The exteriorized mesentery was superfused continuously with warm endotoxin-free isotonic saline solution, pH 7.4, and parts of the intestine which were not microscopically observed were covered with isotonic saline-soaked cotton pads. This was followed by cannulation of a side branch of the terminal superior mesentery artery with a polyethylene catheter. CFDA-labeled HL-60 cells were injected through the cannulated artery as de~cribed.'~.'~ Venular blood flow was reduced by partial occlusion of the superior mesenteric artery using an inflatable balloon catheter, as described previously with slight modification^.^^ After insertion of PElO polyethylene catheter into the arterial side branch upstream from a vascular area chosen for microscopic observation, a balloon catheter was gently wrapped and tied around the main stem of the superior mesenAdhesion assay.
Intravital microscopy studies.
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From tery artery (upstream of the cannulated side branch). The balloon catheter was attached to an air-filled syringe. Controlled inflation of the balloon resulted in regulating the blood flow through the mesentery artery. The collateral circulation through the ileum was also blocked using occluder clamps. Regulation of the blood flow in microvascular segment for short and intermittent duration of times had no effect on local hemodynamics and was rever~ible.~~ Initial video recording were obtained to determine the baseline adhesion of CFDA-labeled HL-60 cells in the venules. Subsequently, the mesenteric blood flow was reduced by a regulated inflation of the balloon catheter followed by administration of injected HL-60 cells through the catheter downstream from the occlusion site. The balloon catheter was deflated between injections. CFDA-labeled HL-60 cells (0.2 to 0.5 X IO') injected under the various conditions tested, and passing through mesenteric vessels (35-to 60-pm diameter) in the downstream circulation, were made visible by stroboscopic epi-illumination using a video triggered Xenon lamp (Chadwick Helmuth, Mountain View, CA) and a Leitz Ploemopak epi-illuminator employing an I2 filter block. The images were recorded through a siliconintensified tube camera (SIT68; Dage MTI, Michigan City, IN) using a X10/0.13 water immersion objective (Nikon, Melville, NY) and a SVHS video recorder (JVC HC-6600; Japan). Video recordings were analyzed off-line by two individuals for assessment of HL-60 cell adhesion by counting the total number of adherent CFDA-labeled cells per venule. A cell was considered adherent to venular endothelium if it remained stationary for longer than 30 seconds. HL-60 cell adhesion before or after treatment with control, or fibrinogen ychain-derived synthetic peptides was separately determined by frame-by-frame analysis of video recorded images. The centerline blood flow velocity (Vc) in each venule was determined as Vc = 2 X Vmax/2 -(DcDv),' as previously described26 where Vmar is the maximum velocity measured in each sample and Dc and Dv are the diameters of HL-60 cells and of the venules, respectively. The wall shear rate was calculated as previously described" (Vc11.6) X (I/ Dv) x 8 (s-'), and shear stress acting on HL-60 cells was determined as: wall shear rate X 0.025 (dyne/") where 0.025 is the approximate blood viscosity in Poise. For all experiments, data were expressed as number of adherent cells/venule. Statistical analysis of HL-60 cell adhesion to endothelium under the various conditions tested was performed by multiple comparisons of paired data by Student's t-test using a statistical software package (Sigmastat, Jandel Scientific). P values of <.05 were considered statistically significant. All results are given as mean 2 SD.
RESULTS
Fibrinogen-dependent leukocyte-endothelial cell interaction. Vitamin D3-differentiated monocytic HL-60 cells'8 did not constitutively adhere to rabbit endothelium, under physiologic and reduced conditions of blood flow (Fig 1) .
Stimulation of HL-60 cells with IO pmoVL fMLP, which upregulates CDI Ib/CDI 8 ligand binding,7 or addition of 300 pg/mL of human fibrinogen, resulted in detectable levels of monocytic cell adhesion to endothelium under reduced flow conditions (shear stress: 1.7 1 2 0.47 dyne/cm2) (fMLP-stimulated: 1.55 2 0.88 cells/venule; n = 7 venules in 4 rabbits ie, n = 7/4; P = .002 v unstimulated cells; fibrinogen-equilibrated cells: 1.14 2 0.69/venule; n = 7/4; P = .011 v untreated cells) (Fig I) . Under these conditions of shear stress (range: 0.77 to 2.79 dyne/cm2), binding of fibrinogen to fMLP-stimulated HL-60 cells resulted in a threefold to fivefold enhancement of adhesion of monocytic cells to venular endothelium (6. (Fig 1) . The enhancing effect of fibrinogen on monocytic cellendothelium interaction in vivo was concentration-dependent (4.7 to 7.8 cells/venule, Fig 1) and regulated by flow shear forces. At physiological shear rates (1 1.67 2 4.59 dyne/cm2; range 3.38 to 17.8 dyne/cm2), fibrinogen did not enhance monocytic cell adhesion to endothelium (0.57 2 1.13 cells/venule), compared with control incubations stimulated with fMLP alone (fMLP-treated cells: 0.62 ? 1.4 cells/ venule; fibrinogen-equilibrated cells: 0.5 1 2 1.2 cells/venules; n = 5/3) (Fig 1) . On the other hand, HL-60 cells attached to venular endothelium in the presence of fibrinogen at reduced shear rates (68.2 2 18.8 s-'), did not disengage from the vessel wall upon increase in the venular shear rate (467 2 183 s-I) (data not shown). As morphologically characterized in Fig 2, fibrinogen mediated firm attachment of leukocytes to mesentery endothelial cells, and no leukocyte rolling was observed under these experimental conditions in the presence or in the absence of fibrinogen (Fig 2) . and in agreement with previous (see Discussion). Finally, the enhancing effect of fibrinogen on leukocyteendothelial cell interaction was exclusively observed in venules, but not in arterioles or capillaries (Fig 2) .
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From The possibility that circulating rabbit fibrinogen may contribute to this pathway of intercellular adhesion was investigated. Monocytic THP-1 cells. which constitutively express the fibrinogen receptor CDI IbKD18 and bind fibrinogen in a reaction quantitatively indistinguishable from that of vitamin D3-differentiated HL-60 cells?,'x adhered to human fibrinogen-coated plates in a specific and concentration-dependent reaction (Fig 3) , completely inhibited by anti-CDI 8 3000 1 ' " ool .
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Substrate concentration (pg/ml) MoAb IB4 (not shown), in agreement with previous observations.' In contrast, rabbit fibrinogen, or comparable concentrations of control protein transferrin, did not support human monocytic cell attachment, under the same experimental conditions (Fig 3) .
ICAM-I-dependent leukocyte-endothelium bridging in vivo.
Previous studies indicated that ICAM-I acted as a novel endothelial cell fibrinogen receptor, mediating fibrinogen-dependent leukocyte adhesion and transendothelial cell
The potential role of ICAM-I in fibrinogendependent leukocyte adhesion to rabbit endothelium in vitro and in vivo was investigated. First, and consistent with the in vivo data presented above, pre-equilibration with human fibrinogen enhanced by twofold to threefold and in a timedependent manner the adhesion of monocytic THP-I cells to monolayers of rabbit endothelial cells, compared with control incubation in the presence of transferrin (Fig 4A) . This reaction was quantitatively indistinguishable from the enhancement of monocytic THP-I cell adhesion to human endothelium mediated by fibrinogen (Fig 4A) . in agreement with previous Indistinguishable results were also obtained with vitamin D3-differentiated HL-60 cells (not shown). Preincubation of human or rabbit endothelial cells with saturating concentrations of the functionally blocking anti-ICAM-1 MoAbs LB-2 or 2D5, completely inhibited the fibrinogen-dependent component of leukocyte adhesion to either endothelial cell type (Fig 4B) . In contrast, comparable concentrations of control, nonbinding MoAb 14E11 were ineffective, under the same experimental conditions (Fig 4B) . The potential role of ICAM-I in fibrinogendependent intercellular bridging in vivo was also investigated. A synthetic peptide from the fibrinogen y-chain sequence N"7NQKIVNLKEKVAQLEA'33 designated y3, bound to ICAM-1 transfectants and inhibited fibrinogen association with ICAM-1 .2J Increasing concentrations of y3 blocked fibrinogen-dependent leukocyte-endothelium interaction at reduced shear stress (<2.8 dyne/cm'), in a dosedependent manner with ICso -200 pmol/L (Fig 5) . Under the experimental conditions of cell number and shear forces used in this study, y3 concentrations of 1 mg/mL significantly inhibited the enhancing effect of fibrinogen on leukocyte-endothelium interaction in vivo to background levels observed in the absence of fibrinogen (1.25 t 0.847 cells/ venule; n = 8/4; P < .001 v fibrinogen-containing samples) (Figs 5 and 6A) . In contrast, comparable concentrations of a control scrambled peptide synthesized with the y3 sequence in random order (5.1 2 1.732 cells/venule; n = 1 I/ 4; P > .5 v control) (Figs 5 and 6B) , or the y-chain LIO peptide L e~~~' -V a l~" (5.66 t 1.03 cells/venule, n = 5/3; P > .5 v control), did not significantly diminish leukocyteendothelium interaction, under the same experimental conditions (Figs 5 and 6 ).
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DISCUSSION
In this study, we have shown that fibrinogen mediates attachment of monocytic cells to rabbit mesentery endothelium in vivo by acting as a bridging molecule between the two cell types. This pathway of intercellular adhesion was observed in venules, but not in arterioles or capillaries, was effective at reduced shear forces, and occurred through the recognition of the fibrinogen y-chain sequence A~n"'-Ala''~ by ICAM-1 on the endothelium. Consistent with this model, rabbit fibrinogen did not mediate human leukocyte adhesion, whereas rabbit endothelial cells were indistinguishable from human endothelium for their ability to support fibrinogeni l For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From dependent monocytic cell adhesion, in a reaction completely inhibited by anti-ICAM-1 blocking MoAbs LB-2" or 2D5.IX One of the most significant findings of our study was the ability of fibrinogen to mediate a firm type of attachment of monocytic cells to rabbit endothelium in vivo, as opposed to transient leukocyte rolling. Consistent with current models of "adhesion cascade" recapitulating leukocyte-endothelium interaction,'"." this suggests that fibrinogen may cooperate with the recognition of & integrins in stabilizing secondary tight attachment of leukocytes to the vessel wall.'". '7 As compared with other published in vivo studies, the relatively low level of monocytic cell adhesion observed here in the presence of fibrinogen may reflect the stringent experimental protocol selected for this study. Although vitamin D?-differentiated HL-60 cells possess a high-affinity fibrinogen receptor in the CDI Ib/CD18 ir~tegrin,~ these cells lack L-selectin which resulted in absence of leukocyte rolling under our experimental conditions, in agreement with previous observation^.^^.'^ Consistent with this scheme, published studies showed that sialyl-Lewisx-dependent HL-60 cell rolling in comparable in vivo models was exclusively restricted to very early (<20 minutes) or very late (>2 hours) time intervals,".2x in an experimental protocol entirely different from that used in the present study. Finally, no cytokine stimulation of rabbit endothelial cells was performed before to assess the effect of fibrinogen on leukocyte adherence, thus resulting in a low level or absence of E-selectin expression in this model. Based on these considerations, it seems plausible to hypothesize that fibrinogen-dependent intercellular bridging may play an even more prominent role in localizing leukocytes to endothelium in vivo, when physiological rolling mechanisms mediated by selectins/cy4 integrin-sialyl-Lewis" interactions'J.'"."' may contribute an initial transient leukocyte-endothelium tethering.
As anticipated previously, the ability of fibrinogen to mediate leukocyte-endothelium bridging depended on a novel recognition of fibrinogen by ICAM-1 .'. IR In agreement with recent independent contributions,"'.'' this was further substantiated here, where two different classes of antagonists of the ICAM-I -fibrinogen recognition, including anti-ICAM-1 MoAbs LB-2" or 2D5," or the synthetic peptide ~3~' Asn"7-Ala''3, blocked monocytic cell attachment to rabbit endothelial cells mediated by fibrinogen, in vitro or in vivo, respectively. Moreover, the inability of rabbit fibrinogen to support monocyte adherence further lends credibility to our model of intercellular bridging, in which human fibrinogen bound to the leukocyte surface was solely responsible for enhancing monocyte attachment to endothelium, in vitro or in vivo.
The structural topography of the y3 sequence in fibrinogen may help explain the ability of this pathway to mediate intercellular adhesion under physiologic conditions, in vivo. Using epitope-mapped MoAbs, Ugarova et al" showed that part of the 73 sequence may not be accessible in native fibrinogen, while becoming exposed in the conformationally rearranged molecule, immobilized on plastic or bound to a cell-surface receptor. This opens the possibility that initial binding of fibrinogen to activated CDI Ib/CD18 on leukocytes may transduce conformational changes in the ligand thus exposing the y3 sequence for a secondary interaction with ICAM-I on the endothelium. Such sequential receptor cascade on vascular cells may explain the ability of fibrinogen to support leukocyte-endothelium bridging in a physiologic human plasma milieu, containing large concentrations of soluble, potentially competing human fibrinogen.*
The potential pathophysiological relevance of these observations is highlighted by the prominent role of fibrinogen in vascular diseases," and its invariable participation in inflammatory responses, in vivo.'.' The model of fibrinogendependent intercellular bridging in vitro,'.'' and in vivo (this study), may define a potential novel adhesive mechanism promoting leukocyte recruitment and accumulation at the vessel wall, as a prerequisite of inflammatory responses with For personal use only. on September 24, 2017. by guest www.bloodjournal.org From vascular cell acti~ation:~ leukocyte transendothelial migration," and cytokine release.34 On the other hand, this pathway may also aberrantly contribute to the onset and development of vascular injury and thrombus formation, invariably characterized by increased leukocyte attachment to endothel i~m ,~' and complex hemodynamic alteration^.^^ Consistent with the mechanistic model of intercellular adhesion presented here, increased deposition of f i b r i n~g e n~~.~' and increased expression of ICAM-13' have been shown on endothelial cells in all types of atherosclerotic lesions.
In summary, these findings demonstrate the existence of an alternative adhesive pathway of leukocyte-endothelium interaction in V~V O , '~, " and propose a novel pathogenetic role of fibrinogen in the cellular contribution to vascular injury.32 Advanced antagonists of the fibrinogen-ICAM-1 recognition (ie, 7 3 peptide, MoAb 2D5) may prove beneficial at reducing aberrant leukocyte accumulation at the vessel wall in vivo, without interfering with fibrinogen-directed primary and secondary hemostatic functions. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
